Dr. Alison Zhang is a Medical Oncologist at Macquarie University Hospital, Chris O’Brien Lifehouse and an Adjunct Senior Lecturer at Macquarie University Hospital. She focuses on treating Genitourinary (bladder/urothelial, kidney, prostate, testicular and penile) malignancies and is the Bladder Cancer Lead at Macquarie University Hospital and the Bladder/ Kidney Cancer Lead at the Chris O’Brien Lifehouse.

She has completed a translational cancer PhD (Garvan Institute, Sydney), focusing on delineating biomarkers in prostate cancer and a Master of Clinical Epidemiology (focusing on statistical methods and clinical trial design). She is currently a Senior Oncology Research Fellow at the NHMRC Clinical Trials Unit, as part of the University of Sydney, where she is comprehensively involved in trial design, conduct and analysis of academic genitourinary trials. She is the Macquarie University and Chris O’Brien Lifehouse principal investigator on more than 15 Phase I-III studies.

Her research has been published in peer-reviewed, high impact factor journals, including the New England Journal of Medicine, Lancet, Lancet Oncology, Journal of Clinical Oncology and Annals of Oncology. She also sits on several ANZUP trial management committees and is an active member of the European Society of Medical Oncology (ESMO), American Society of Clinical Oncology (ASCO), Medical Oncology Group of Australia (MOGA), and Australia and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP).